Sheryl Kingsberg: Bremelanotide (BMT) for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies (Introduced by C. Egarter)
Symposium: (OL02) Hypoactive sexual desire disorder: addressing an unmet medical need
Presented at the 13 Congress of the European Society of Gynecology – 2019